Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Am J Drug Alcohol Abuse ; 48(5): 618-628, 2022 09 03.
Artículo en Inglés | MEDLINE | ID: mdl-36194086

RESUMEN

Background: Most research on opioid misuse focuses on younger adults, yet opioid-related mortality has risen fastest among older Americans over age 55.Objectives: To assess whether there are differential patterns of opioid misuse over time between younger and older adults and whether South Carolina's mandatory Prescription Drug Monitoring Program (PDMP) affected opioid misuse differentially between the two groups.Methods: We used South Carolina's Reporting and Identification Prescription Tracking System from 2010 to 2018 to calculate an opioid misuse score for 193,073 patients (sex unknown) using days' supply, morphine milligram equivalents (MME), and the numbers of unique prescribers and dispensaries. Multivariable regression was used to assess differential opioid misuse patterns by age group over time and in response to implementation of South Carolina's mandatory PDMP in 2017.Results: We found that between 2011 and 2018, older adults received 57% (p < .01) more in total MME and 25.4 days more (p < .01) in supply, but received prescriptions from fewer doctors (-0.063 doctors, p < 01) and pharmacies (-0.11 pharmacies, p < 01) per year versus younger adults. However, older adults had lower odds of receiving a high misuse score (OR 0.88, p < .01). After the 2017 legislation, misuse scores fell among younger adults (OR 0.79, p < .01) relative to 2011, but not among older adults.Conclusion: Older adults may misuse opioids differently compared to younger adults. Assessment of policies to reduce opioid misuse should take into account subgroup differences that may be masked at the population level.


Asunto(s)
Trastornos Relacionados con Opioides , Mal Uso de Medicamentos de Venta con Receta , Programas de Monitoreo de Medicamentos Recetados , Anciano , Analgésicos Opioides/uso terapéutico , Endrín/análogos & derivados , Humanos , Lactante , Derivados de la Morfina , Trastornos Relacionados con Opioides/tratamiento farmacológico , Trastornos Relacionados con Opioides/epidemiología , Pautas de la Práctica en Medicina , South Carolina/epidemiología , Estados Unidos
2.
Sci Rep ; 14(1): 22066, 2024 09 27.
Artículo en Inglés | MEDLINE | ID: mdl-39333260

RESUMEN

At the beginning of the COVID-19 pandemic in the US, traffic sharply fell due to social distancing policies in many locations. Correspondingly, many regions observed an increase in traffic volume (traffic recovery) as the pandemic eased in 2022. We examine how vaccination rates influence traffic recovery in Los Angeles County (LAC), controlling for differences in case counts, demographics, and socioeconomic factors across areas with different vaccination rates. We use arterial road sensor data as a proxy for the traffic volume within each ZIP code, alongside their respective demographic and socioeconomic characteristics. We find that a higher vaccination rate is statistically significantly associated with a larger traffic recovery, a finding that remains consistent across all explored models. This implies that an increased vaccination rate could reduce the public's perception of the risks of disease infection, leading to a larger traffic recovery. Moreover, we found that variables including population, income, race, work industry, and commuting preferences were correlated with vaccination rates. This highlights potential inequalities based on race, income, and industry sectors in the COVID-19 vaccination and a return to normal traffic flow.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Vacunación , Humanos , COVID-19/prevención & control , COVID-19/epidemiología , Vacunas contra la COVID-19/administración & dosificación , Vacunación/estadística & datos numéricos , SARS-CoV-2/inmunología , Los Angeles/epidemiología , Factores Socioeconómicos , Transportes , Pandemias/prevención & control
3.
JHEP Rep ; 3(6): 100367, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34825154

RESUMEN

BACKGROUND & AIMS: Uncertainties exist surrounding the timing of liver transplantation (LT) among patients with acute-on-chronic liver failure grade 3 (ACLF-3), regarding whether to accept a marginal quality donor organ to allow for earlier LT or wait for either an optimal organ offer or improvement in the number of organ failures, in order to increase post-LT survival. METHODS: We created a Markov decision process model to determine the optimal timing of LT among patients with ACLF-3 within 7 days of listing, to maximize overall 1-year survival probability. RESULTS: We analyzed 6 groups of candidates with ACLF-3: patients age ≤60 or >60 years, patients with 3 organ failures alone or 4-6 organ failures, and hepatic or extrahepatic ACLF-3. Among all groups, LT yielded significantly greater overall survival probability vs. remaining on the waiting list for even 1 additional day (p <0.001), regardless of organ quality. Creation of 2-way sensitivity analyses, with variation in the probability of receiving an optimal organ and expected post-transplant mortality, indicated that overall survival is maximized by earlier LT, particularly among candidates >60 years old or with 4-6 organ failures. The probability of improvement from ACLF-3 to ACLF-2 does not influence these recommendations, as the likelihood of organ recovery was less than 10%. CONCLUSION: During the first week after listing for patients with ACLF-3, earlier LT in general is favored over waiting for an optimal quality donor organ or for recovery of organ failures, with the understanding that the analysis is limited to consideration of only these 3 variables. LAY SUMMARY: In the setting of grade 3 acute-on-chronic liver failure (ACLF-3), questions remain regarding the timing of transplantation in terms of whether to proceed with liver transplantation with a marginal donor organ or to wait for an optimal liver, and whether to transplant a patient with ACLF-3 or wait until improvement to ACLF-2. In this study, we used a Markov decision process model to demonstrate that earlier transplantation of patients listed with ACLF-3 maximizes overall survival, as opposed to waiting for an optimal donor organ or for improvement in the number of organ failures.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA